FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> Data Aggregation | clinical data

Drug makers need help leveraging IT

Tools

Time spent gathering and analyzing data from multiple sources is the biggest challenge facing both small/medium and large drug makers, say respondents to a recent survey. In addition, more than 60 percent of 538 manufacturing professional respondents report "moderate" or "significant" variability in their manufacturing processes.

Results indicate that more than half of small/medium companies use home-grown data aggregation systems, while large companies more often use data historians and data warehouses, reports Aegis Analytical, which conducted the survey.

The analysis finds that "data aggregation frustration" affects not just batch investigations but also regulatory audits and annual product reviews. The overall survey finding is that existing IT investments are not being leveraged. Large companies that have invested more heavily than their smaller counterparts in IT infrastructure, but even those using lab, manufacturing and enterprise software systems still report spending too much time collecting data.

Consultant Michael McClellan, writing in our op-ed section, says "what is needed is an easy method to extract data from each information source to build an electronic file to match the master batch record format." He has a project underway to do just that.

- access the survey report here
- click here to learn about McClellan's project 


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:
Be the first to comment
More stories about Data Aggregation   clinical data  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.